Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study of MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Therapy

    • Cancer
    • Bladder Cancer
    • Urothelial Carcinoma